Cochlear Revenue

In the fiscal year ending June 30, 2025, Cochlear had annual revenue of 2.34B AUD with 4.81% growth. Cochlear had revenue of 1.17B in the half year ending June 30, 2025, with 11.46% growth.

Revenue

2.34B

Revenue Growth

+4.81%

P/S Ratio

7.82

Revenue / Employee

426.02K

Employees

5,500

Market Cap

18.31B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	2.34B	107.50M	4.81%
Jun 30, 2024	2.24B	299.50M	15.47%
Jun 30, 2023	1.94B	287.80M	17.46%
Jun 30, 2022	1.65B	150.70M	10.06%
Jun 30, 2021	1.50B	177.00M	13.40%
Jun 30, 2020	Pro	Pro	Pro
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro
Jun 30, 2017	Pro	Pro	Pro
Jun 30, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
CSL Limited	23.73B
Pro Medicus	212.98M
Sonic Healthcare	9.65B
Ramsay Health Care	17.79B
Telix Pharmaceuticals	1.01B
Ansell	3.06B
Mesoblast	26.23M
Neuren Pharmaceuticals	218.86M

Revenue Rankings

Cochlear News

6 weeks ago - Cochlear reports FY results - Seeking Alpha
6 weeks ago - Cochlear Ltd (CHEOF) (FY25) Earnings Call Highlights: Navigating Growth and Challenges - GuruFocus
6 weeks ago - Cochlear CEO depends on built-up inventory as some export licenses lag - CNBC
6 weeks ago - Full Year 2025 Cochlear Ltd Earnings Call Transcript - GuruFocus
6 weeks ago - Cochlear Limited 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
6 weeks ago - Cochlear Limited (CHEOF) Q4 2025 Earnings Call Transcript - Seeking Alpha
6 weeks ago - Cochlear tips higher earnings this year, slower first-half - The Australian Financial Review
6 weeks ago - ASX 200 LIVE: ASX to open modestly higher, results pending from Cochlear, Mirvac, US equities end little changed - The Australian Financial Review

More News